Fenoldopam

CAT:
804-HY-B0735
Size:
1 Each

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Fenoldopam - image 1

Fenoldopam

  • Description:

    Fenoldopam (SKF 82526) is a drug and synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist. Target: D1 Receptor Fenoldopam is a selective dopamine-1 (DA1) agonist with natriuretic/diuretic properties. Fenoldopam stimulated cAMP accumulation in LLC-PK1 cells in a dose-dependent manner, an effect which could be blocked by the DA1-selective antagonist Sch 23390. Although fenoldopam was more potent than DA (EC50 55.5 +/- 7.75 nM vs. 1.65 +/- 0.64 microM) in stimulating cAMP accumulation in LLC-PK1 cells, the maximum stimulation obtained by fenoldopam was only 37% of the maximum stimulation obtained by DA (Emax 13.0 +/- 2.95 pmol/mg of protein vs. 35.6 +/- 10.19 pmol/mg of protein) [1]. Fenoldopam is a selective dopamine1 (DA1) receptor agonist. Most of the DA1 receptor agonist activity of fenoldopam resides in the R-enantiomer, which also shows weaker alpha 2-adrenoceptor antagonist activity Fenoldopam produces vasodilation in vascular beds that are rich in vascular DA1 receptors [2].
  • Product Name Alternative:

    SKF 82526
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302-H317-H319-H334
  • Target:

    Dopamine Receptor
  • Type:

    Reference compound
  • Related Pathways:

    GPCR/G Protein; Neuronal Signaling
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/fenoldopam.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    OC1=C (O) C=C2C (C3=CC=C (O) C=C3) CNCCC2=C1Cl
  • Molecular Formula:

    C16H16ClNO3
  • Molecular Weight:

    305.76
  • Precautions:

    P261-P264-P270-P272-P280-P285-P302+P352-P305+P351+P338-P330-P363-P501
  • References & Citations:

    [1]Grenader, A. and D.P. Healy, Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther, 1991. 258 (1) : p. 193-8.|[2]Nichols, A.J., R.R. Ruffolo, Jr., and D.P. Brooks, The pharmacology of fenoldopam. Am J Hypertens, 1990. 3 (6 Pt 2) : p. 116S-119S.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • Citation 01:

    Biochem Biophys Res Commun. 2022 Jan 15:588:83-89.|Biomed Pharmacother. 2021 Jul:139:111500.|SLAS Discov. 2020 Sep;25 (8) :895-905.|Cell. 2021 Feb 18;184 (4) :943-956.e18.
  • CAS Number:

    67227-56-9